Aşırı aktif mesane (Turkish Wikipedia)
Analysis of information sources in references of the Wikipedia article "Aşırı aktif mesane" in Turkish language version.
refsWebsite
Global rank
Turkish rank
1st place
1st place
5th place
8th place
3rd place
5th place
102nd place
447th place
6th place
6th place
low place
low place
low place
low place
low place
low place
7,197th place
low place
low place
low place
low place
low place
3,258th place
6,339th place
49th place
74th place
18th place
47th place
archive.org
- Sussman DO (September 2007). "Overactive bladder: treatment options in primary care medicine". The Journal of the American Osteopathic Association. 107 (9): 379-85. PMID 17908830.
- Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ (June 2001). "How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study". BJU International. 87 (9): 760-6. doi:10.1046/j.1464-410x.2001.02228.x. PMID 11412210.
auanet.org
- American Urological Association (2014). "Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline" (PDF). 26 Nisan 2015 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 1 Haziran 2015.
bond.edu.au
epublications.bond.edu.au
- Moro C, Uchiyama J, Chess-Williams R (December 2011). "Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol". Urology. 78 (6): 1442.e9-15. doi:10.1016/j.urology.2011.08.039. PMID 22001099.
books.google.com
- Gibbs, Ronald S. (2008). Danforth's obstetrics and gynecology (10 bas.). Philadelphia: Lippincott Williams & Wilkins. ss. 890-891. ISBN 9780781769372. 5 Mart 2016 tarihinde kaynağından arşivlendi.
- Ghosh, Amit K. (2008). Mayo Clinic internal medicine concise textbook. Rochester, MN: Mayo Clinic Scientific Press. s. 339. ISBN 9781420067514. 5 Mart 2016 tarihinde kaynağından arşivlendi.
- Abrams, Paul (2011). Overactive bladder syndrome and urinary incontinence. Oxford: Oxford University Press. ss. 7-8. ISBN 9780199599394. 5 Mart 2016 tarihinde kaynağından arşivlendi.
choosingwisely.org
- American Urogynecologic Society (5 Mayıs 2015), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American Urogynecologic Society, 2 Haziran 2015 tarihinde kaynağından arşivlendi, erişim tarihi: 1 Haziran 2015
consumerhealthchoices.org
- Consumer Reports Health Best Buy Drugs (June 2010). "Evaluating Prescription Drugs to Treat: Overactive Bladder - Comparing Effectiveness, Safety, and Price". Best Buy Drugs: 10. 21 Eylül 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Eylül 2012., which cites "Overactive Bladder Drugs". Drug Effectiveness Review Project. Oregon Health & Science University. 23 Nisan 2011 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Eylül 2013.
cornellurology.com
- "Overactive Bladder". Cornell University Weill Cornell Medical College Department of Urology. 21 Eylül 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Ağustos 2013.
doi.org
- Gormley EA, Lightner DJ, Faraday M, Vasavada SP (May 2015). "Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment". The Journal of Urology. 193 (5): 1572-80. doi:10.1016/j.juro.2015.01.087. PMID 25623739.
- Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE, Scarpero HM, Tessier CD, Vasavada SP (December 2012). "Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline". The Journal of Urology. 188 (6 Suppl): 2455-63. doi:10.1016/j.juro.2012.09.079. PMID 23098785.
- Hargreaves, Emma; Baker, Katherine; Barry, Gill; Harding, Christopher; Zhang, Yingying; Kandala, Ngianga-Bakwin; Zhang, Xiaowen; Kernohan, Ashleigh; Clarkson, Carl E (23 Eylül 2022). Cochrane Incontinence Group (Ed.). "Acupuncture for treating overactive bladder in adults". Cochrane Database of Systematic Reviews (İngilizce). 2022 (9): CD013519. doi:10.1002/14651858.CD013519.pub2. PMC 9502659 $2. PMID 36148895.
- Ruxton K, Woodman RJ, Mangoni AA (August 2015). "Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis". British Journal of Clinical Pharmacology. 80 (2): 209-20. doi:10.1111/bcp.12617. PMC 4541969 $2. PMID 25735839.
- Stewart F, Gameiro LF, El Dib R, Gameiro MO, Kapoor A, Amaro JL (December 2016). "Electrical stimulation with non-implanted electrodes for overactive bladder in adults". The Cochrane Database of Systematic Reviews. 12 (2): CD010098. doi:10.1002/14651858.CD010098.pub4. hdl:2164/8446. PMC 6463833 $2. PMID 27935011.
- Lightner, Deborah J.; Gomelsky, Alexander; Souter, Lesley; Vasavada, Sandip P. (September 2019). "Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019". The Journal of Urology. 202 (3): 558-563. doi:10.1097/JU.0000000000000309. ISSN 1527-3792. PMID 31039103.
- Wein A (October 2011). "Symptom-based diagnosis of overactive bladder: an overview". Canadian Urological Association Journal. 5 (Suppl 2): S135-6. doi:10.5489/cuaj.11183. PMC 3193392 $2. PMID 21989525.
- Tikkinen KA, Johnson TM, Tammela TL, Sintonen H, Haukka J, Huhtala H, Auvinen A (March 2010). "Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland". European Urology. 57 (3): 488-96. doi:10.1016/j.eururo.2009.03.080. PMID 19361907.
- Sacco E (2012). "[Physiopathology of overactive bladder syndrome]". Urologia. 79 (1): 24-35. doi:10.5301/RU.2012.8972. PMID 22287269.
- Moro C, Uchiyama J, Chess-Williams R (December 2011). "Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol". Urology. 78 (6): 1442.e9-15. doi:10.1016/j.urology.2011.08.039. PMID 22001099.
- Shy M, Fletcher SG (March 2013). "Objective Evaluation of Overactive Bladder: Which Surveys Should I Use?". Current Bladder Dysfunction Reports. 8 (1): 45-50. doi:10.1007/s11884-012-0167-2. PMC 3579666 $2. PMID 23439804.
- Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA (October 1994). "Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group". Quality of Life Research. 3 (5): 291-306. doi:10.1007/bf00451721. PMID 7841963.
- Coyne K, Schmier J, Hunt T, Corey R, Liberman J, Revicki D (March 2000). "PRN6: developing a specific HRQL instrument for overactive bladder". Value in Health. 3 (2): 141. doi:10.1016/s1098-3015(11)70554-x.
- Homma Y (January 2008). "Lower urinary tract symptomatology: Its definition and confusion". International Journal of Urology. 15 (1): 35-43. doi:10.1111/j.1442-2042.2007.01907.x. PMID 18184169.
- Anger JT, Le TX, Nissim HA, Rogo-Gupta L, Rashid R, Behniwal A, Smith AL, Litwin MS, Rodriguez LV, Wein AJ, Maliski SL (November 2012). "How dry is "OAB-dry"? Perspectives from patients and physician experts". The Journal of Urology. 188 (5): 1811-5. doi:10.1016/j.juro.2012.07.044. PMC 3571660 $2. PMID 22999694.
- Funada, Satoshi; Yoshioka, Takashi; Luo, Yan; Sato, Akira; Akamatsu, Shusuke; Watanabe, Norio (9 Ekim 2023). "Bladder training for treating overactive bladder in adults". The Cochrane Database of Systematic Reviews. 2023 (10): CD013571. doi:10.1002/14651858.CD013571.pub2. ISSN 1469-493X. PMC 10561149 $2. PMID 37811598.
- Rai, Bhavan Prasad; Cody, June D.; Alhasso, Ammar; Stewart, Laurence (12 Aralık 2012). "Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults". The Cochrane Database of Systematic Reviews. 12 (12): CD003193. doi:10.1002/14651858.CD003193.pub4. ISSN 1469-493X. PMC 7017858 $2. PMID 23235594.
- Balk, Ethan M.; Rofeberg, Valerie N.; Adam, Gaelen P.; Kimmel, Hannah J.; Trikalinos, Thomas A.; Jeppson, Peter C. (2019). "Pharmacologic and Nonpharmacologic Treatments for Urinary Incontinence in Women: A Systematic Review and Network Meta-analysis of Clinical Outcomes". Annals of Internal Medicine (İngilizce). 170 (7): 465-480. doi:10.7326/M18-3227. ISSN 0003-4819. PMID 30884526.
- Araklitis G, Cardozo L (November 2017). "Safety issues associated with using medication to treat overactive bladder". Expert Opinion on Drug Safety. 16 (11): 1273-1280. doi:10.1080/14740338.2017.1376646. PMID 28889761.
- Sacco E, Bientinesi R (December 2012). "Mirabegron: a review of recent data and its prospects in the management of overactive bladder". Therapeutic Advances in Urology. 4 (6): 315-24. doi:10.1177/1756287212457114. PMC 3491758 $2. PMID 23205058.
- Sacco E, Paolillo M, Totaro A, Pinto F, Volpe A, Gardi M, Bassi PF (2008). "Botulinum toxin in the treatment of overactive bladder". Urologia. 75 (1): 4-13. doi:10.1177/039156030807500102. PMID 21086369.
- Sacco E, Pinto F, Bassi P (April 2008). "Emerging pharmacological targets in overactive bladder therapy: experimental and clinical evidences". International Urogynecology Journal and Pelvic Floor Dysfunction. 19 (4): 583-98. doi:10.1007/s00192-007-0529-z. PMID 18196198.
- Sacco E, ve diğerleri. (2009). "Investigational drug therapies for overactive bladder syndrome: the potential alternatives to anticholinergics". Urologia. 76 (3): 161-177. doi:10.1177/039156030907600301. PMID 21086288.
- Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ (May 2003). "Prevalence and burden of overactive bladder in the United States". World Journal of Urology. 20 (6): 327-36. doi:10.1007/s00345-002-0301-4. hdl:2027.42/42170. PMID 12811491.
- Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ (June 2001). "How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study". BJU International. 87 (9): 760-6. doi:10.1046/j.1464-410x.2001.02228.x. PMID 11412210.
- Tikkinen KA, Tammela TL, Rissanen AM, Valpas A, Huhtala H, Auvinen A (February 2007). Madersbacher S (Ed.). "Is the prevalence of overactive bladder overestimated? A population-based study in Finland". PLOS ONE. 2 (2): e195. Bibcode:2007PLoSO...2..195T. doi:10.1371/journal.pone.0000195. PMC 1805814 $2. PMID 17332843.
handle.net
hdl.handle.net
- Stewart F, Gameiro LF, El Dib R, Gameiro MO, Kapoor A, Amaro JL (December 2016). "Electrical stimulation with non-implanted electrodes for overactive bladder in adults". The Cochrane Database of Systematic Reviews. 12 (2): CD010098. doi:10.1002/14651858.CD010098.pub4. hdl:2164/8446. PMC 6463833 $2. PMID 27935011.
- Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ (May 2003). "Prevalence and burden of overactive bladder in the United States". World Journal of Urology. 20 (6): 327-36. doi:10.1007/s00345-002-0301-4. hdl:2027.42/42170. PMID 12811491.
harvard.edu
adsabs.harvard.edu
- Tikkinen KA, Tammela TL, Rissanen AM, Valpas A, Huhtala H, Auvinen A (February 2007). Madersbacher S (Ed.). "Is the prevalence of overactive bladder overestimated? A population-based study in Finland". PLOS ONE. 2 (2): e195. Bibcode:2007PLoSO...2..195T. doi:10.1371/journal.pone.0000195. PMC 1805814 $2. PMID 17332843.
loc.gov
webarchive.loc.gov
- Consumer Reports Health Best Buy Drugs (June 2010). "Evaluating Prescription Drugs to Treat: Overactive Bladder - Comparing Effectiveness, Safety, and Price". Best Buy Drugs: 10. 21 Eylül 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Eylül 2012., which cites "Overactive Bladder Drugs". Drug Effectiveness Review Project. Oregon Health & Science University. 23 Nisan 2011 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Eylül 2013.
nationalincontinence.com
- Pham, Nancy. "Get Control Over Your Bladder with a Vibrating Reminder". National Incontinence. 14 Ekim 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ekim 2012.
- Mercer, Renee. "Strategies to Control Incontinence". National Incontinence. 14 Ekim 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Eylül 2012.
nice.org.uk
- "Overview | Urinary incontinence and pelvic organ prolapse in women: management | Guidance | NICE". www.nice.org.uk. 2 Nisan 2019. 24 Nisan 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Nisan 2023.
nih.gov
ncbi.nlm.nih.gov
- Gormley EA, Lightner DJ, Faraday M, Vasavada SP (May 2015). "Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment". The Journal of Urology. 193 (5): 1572-80. doi:10.1016/j.juro.2015.01.087. PMID 25623739.
- Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE, Scarpero HM, Tessier CD, Vasavada SP (December 2012). "Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline". The Journal of Urology. 188 (6 Suppl): 2455-63. doi:10.1016/j.juro.2012.09.079. PMID 23098785.
- Hargreaves, Emma; Baker, Katherine; Barry, Gill; Harding, Christopher; Zhang, Yingying; Kandala, Ngianga-Bakwin; Zhang, Xiaowen; Kernohan, Ashleigh; Clarkson, Carl E (23 Eylül 2022). Cochrane Incontinence Group (Ed.). "Acupuncture for treating overactive bladder in adults". Cochrane Database of Systematic Reviews (İngilizce). 2022 (9): CD013519. doi:10.1002/14651858.CD013519.pub2. PMC 9502659 $2. PMID 36148895.
- Ruxton K, Woodman RJ, Mangoni AA (August 2015). "Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis". British Journal of Clinical Pharmacology. 80 (2): 209-20. doi:10.1111/bcp.12617. PMC 4541969 $2. PMID 25735839.
- Stewart F, Gameiro LF, El Dib R, Gameiro MO, Kapoor A, Amaro JL (December 2016). "Electrical stimulation with non-implanted electrodes for overactive bladder in adults". The Cochrane Database of Systematic Reviews. 12 (2): CD010098. doi:10.1002/14651858.CD010098.pub4. hdl:2164/8446. PMC 6463833 $2. PMID 27935011.
- Lightner, Deborah J.; Gomelsky, Alexander; Souter, Lesley; Vasavada, Sandip P. (September 2019). "Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019". The Journal of Urology. 202 (3): 558-563. doi:10.1097/JU.0000000000000309. ISSN 1527-3792. PMID 31039103.
- Wein A (October 2011). "Symptom-based diagnosis of overactive bladder: an overview". Canadian Urological Association Journal. 5 (Suppl 2): S135-6. doi:10.5489/cuaj.11183. PMC 3193392 $2. PMID 21989525.
- Tikkinen KA, Johnson TM, Tammela TL, Sintonen H, Haukka J, Huhtala H, Auvinen A (March 2010). "Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland". European Urology. 57 (3): 488-96. doi:10.1016/j.eururo.2009.03.080. PMID 19361907.
- Sacco E (2012). "[Physiopathology of overactive bladder syndrome]". Urologia. 79 (1): 24-35. doi:10.5301/RU.2012.8972. PMID 22287269.
- Sussman DO (September 2007). "Overactive bladder: treatment options in primary care medicine". The Journal of the American Osteopathic Association. 107 (9): 379-85. PMID 17908830.
- Moro C, Uchiyama J, Chess-Williams R (December 2011). "Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol". Urology. 78 (6): 1442.e9-15. doi:10.1016/j.urology.2011.08.039. PMID 22001099.
- Shy M, Fletcher SG (March 2013). "Objective Evaluation of Overactive Bladder: Which Surveys Should I Use?". Current Bladder Dysfunction Reports. 8 (1): 45-50. doi:10.1007/s11884-012-0167-2. PMC 3579666 $2. PMID 23439804.
- Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA (October 1994). "Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group". Quality of Life Research. 3 (5): 291-306. doi:10.1007/bf00451721. PMID 7841963.
- Homma Y (January 2008). "Lower urinary tract symptomatology: Its definition and confusion". International Journal of Urology. 15 (1): 35-43. doi:10.1111/j.1442-2042.2007.01907.x. PMID 18184169.
- Anger JT, Le TX, Nissim HA, Rogo-Gupta L, Rashid R, Behniwal A, Smith AL, Litwin MS, Rodriguez LV, Wein AJ, Maliski SL (November 2012). "How dry is "OAB-dry"? Perspectives from patients and physician experts". The Journal of Urology. 188 (5): 1811-5. doi:10.1016/j.juro.2012.07.044. PMC 3571660 $2. PMID 22999694.
- Funada, Satoshi; Yoshioka, Takashi; Luo, Yan; Sato, Akira; Akamatsu, Shusuke; Watanabe, Norio (9 Ekim 2023). "Bladder training for treating overactive bladder in adults". The Cochrane Database of Systematic Reviews. 2023 (10): CD013571. doi:10.1002/14651858.CD013571.pub2. ISSN 1469-493X. PMC 10561149 $2. PMID 37811598.
- Rai, Bhavan Prasad; Cody, June D.; Alhasso, Ammar; Stewart, Laurence (12 Aralık 2012). "Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults". The Cochrane Database of Systematic Reviews. 12 (12): CD003193. doi:10.1002/14651858.CD003193.pub4. ISSN 1469-493X. PMC 7017858 $2. PMID 23235594.
- Balk, Ethan M.; Rofeberg, Valerie N.; Adam, Gaelen P.; Kimmel, Hannah J.; Trikalinos, Thomas A.; Jeppson, Peter C. (2019). "Pharmacologic and Nonpharmacologic Treatments for Urinary Incontinence in Women: A Systematic Review and Network Meta-analysis of Clinical Outcomes". Annals of Internal Medicine (İngilizce). 170 (7): 465-480. doi:10.7326/M18-3227. ISSN 0003-4819. PMID 30884526.
- Balk, Ethan; Adam, Gaelen P.; Kimmel, Hannah; Rofeberg, Valerie; Saeed, Iman; Jeppson, Peter; Trikalinos, Thomas (2018). Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update. AHRQ Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). PMID 30516945. 3 Mart 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Nisan 2024.
- Araklitis G, Cardozo L (November 2017). "Safety issues associated with using medication to treat overactive bladder". Expert Opinion on Drug Safety. 16 (11): 1273-1280. doi:10.1080/14740338.2017.1376646. PMID 28889761.
- Sacco E, Bientinesi R (December 2012). "Mirabegron: a review of recent data and its prospects in the management of overactive bladder". Therapeutic Advances in Urology. 4 (6): 315-24. doi:10.1177/1756287212457114. PMC 3491758 $2. PMID 23205058.
- Sacco E, Paolillo M, Totaro A, Pinto F, Volpe A, Gardi M, Bassi PF (2008). "Botulinum toxin in the treatment of overactive bladder". Urologia. 75 (1): 4-13. doi:10.1177/039156030807500102. PMID 21086369.
- Sacco E, Pinto F, Bassi P (April 2008). "Emerging pharmacological targets in overactive bladder therapy: experimental and clinical evidences". International Urogynecology Journal and Pelvic Floor Dysfunction. 19 (4): 583-98. doi:10.1007/s00192-007-0529-z. PMID 18196198.
- Sacco E, ve diğerleri. (2009). "Investigational drug therapies for overactive bladder syndrome: the potential alternatives to anticholinergics". Urologia. 76 (3): 161-177. doi:10.1177/039156030907600301. PMID 21086288.
- Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ (May 2003). "Prevalence and burden of overactive bladder in the United States". World Journal of Urology. 20 (6): 327-36. doi:10.1007/s00345-002-0301-4. hdl:2027.42/42170. PMID 12811491.
- Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ (June 2001). "How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study". BJU International. 87 (9): 760-6. doi:10.1046/j.1464-410x.2001.02228.x. PMID 11412210.
- Tikkinen KA, Tammela TL, Rissanen AM, Valpas A, Huhtala H, Auvinen A (February 2007). Madersbacher S (Ed.). "Is the prevalence of overactive bladder overestimated? A population-based study in Finland". PLOS ONE. 2 (2): e195. Bibcode:2007PLoSO...2..195T. doi:10.1371/journal.pone.0000195. PMC 1805814 $2. PMID 17332843.
nlm.nih.gov
- "Urinary Bladder, Overactive". 28 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Haziran 2015.
- "Urinary catheters". MedlinePlus, the National Institutes of Health's Web site. 9 Mart 2010. 4 Aralık 2010 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Aralık 2010.
ohsu.edu
derp.ohsu.edu
- Consumer Reports Health Best Buy Drugs (June 2010). "Evaluating Prescription Drugs to Treat: Overactive Bladder - Comparing Effectiveness, Safety, and Price". Best Buy Drugs: 10. 21 Eylül 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Eylül 2012., which cites "Overactive Bladder Drugs". Drug Effectiveness Review Project. Oregon Health & Science University. 23 Nisan 2011 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Eylül 2013.
reuters.com
- "FDA approves Botox for loss of bladder control". Reuters. 24 Ağustos 2008. 24 Eylül 2015 tarihinde kaynağından arşivlendi.
web.archive.org
- Gibbs, Ronald S. (2008). Danforth's obstetrics and gynecology (10 bas.). Philadelphia: Lippincott Williams & Wilkins. ss. 890-891. ISBN 9780781769372. 5 Mart 2016 tarihinde kaynağından arşivlendi.
- American Urological Association (2014). "Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline" (PDF). 26 Nisan 2015 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 1 Haziran 2015.
- "Urinary Bladder, Overactive". 28 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Haziran 2015.
- Ghosh, Amit K. (2008). Mayo Clinic internal medicine concise textbook. Rochester, MN: Mayo Clinic Scientific Press. s. 339. ISBN 9781420067514. 5 Mart 2016 tarihinde kaynağından arşivlendi.
- Abrams, Paul (2011). Overactive bladder syndrome and urinary incontinence. Oxford: Oxford University Press. ss. 7-8. ISBN 9780199599394. 5 Mart 2016 tarihinde kaynağından arşivlendi.
- "Urinary catheters". MedlinePlus, the National Institutes of Health's Web site. 9 Mart 2010. 4 Aralık 2010 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Aralık 2010.
- American Urogynecologic Society (5 Mayıs 2015), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American Urogynecologic Society, 2 Haziran 2015 tarihinde kaynağından arşivlendi, erişim tarihi: 1 Haziran 2015
- "Overactive Bladder". Cornell University Weill Cornell Medical College Department of Urology. 21 Eylül 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Ağustos 2013.
- Pham, Nancy. "Get Control Over Your Bladder with a Vibrating Reminder". National Incontinence. 14 Ekim 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ekim 2012.
- Mercer, Renee. "Strategies to Control Incontinence". National Incontinence. 14 Ekim 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 28 Eylül 2012.
- Balk, Ethan; Adam, Gaelen P.; Kimmel, Hannah; Rofeberg, Valerie; Saeed, Iman; Jeppson, Peter; Trikalinos, Thomas (2018). Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update. AHRQ Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US). PMID 30516945. 3 Mart 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Nisan 2024.
- Consumer Reports Health Best Buy Drugs (June 2010). "Evaluating Prescription Drugs to Treat: Overactive Bladder - Comparing Effectiveness, Safety, and Price". Best Buy Drugs: 10. 21 Eylül 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Eylül 2012., which cites "Overactive Bladder Drugs". Drug Effectiveness Review Project. Oregon Health & Science University. 23 Nisan 2011 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Eylül 2013.
- "Overview | Urinary incontinence and pelvic organ prolapse in women: management | Guidance | NICE". www.nice.org.uk. 2 Nisan 2019. 24 Nisan 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Nisan 2023.
- "FDA approves Botox for loss of bladder control". Reuters. 24 Ağustos 2008. 24 Eylül 2015 tarihinde kaynağından arşivlendi.
worldcat.org
- Lightner, Deborah J.; Gomelsky, Alexander; Souter, Lesley; Vasavada, Sandip P. (September 2019). "Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019". The Journal of Urology. 202 (3): 558-563. doi:10.1097/JU.0000000000000309. ISSN 1527-3792. PMID 31039103.
- Funada, Satoshi; Yoshioka, Takashi; Luo, Yan; Sato, Akira; Akamatsu, Shusuke; Watanabe, Norio (9 Ekim 2023). "Bladder training for treating overactive bladder in adults". The Cochrane Database of Systematic Reviews. 2023 (10): CD013571. doi:10.1002/14651858.CD013571.pub2. ISSN 1469-493X. PMC 10561149 $2. PMID 37811598.
- Rai, Bhavan Prasad; Cody, June D.; Alhasso, Ammar; Stewart, Laurence (12 Aralık 2012). "Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults". The Cochrane Database of Systematic Reviews. 12 (12): CD003193. doi:10.1002/14651858.CD003193.pub4. ISSN 1469-493X. PMC 7017858 $2. PMID 23235594.
- Balk, Ethan M.; Rofeberg, Valerie N.; Adam, Gaelen P.; Kimmel, Hannah J.; Trikalinos, Thomas A.; Jeppson, Peter C. (2019). "Pharmacologic and Nonpharmacologic Treatments for Urinary Incontinence in Women: A Systematic Review and Network Meta-analysis of Clinical Outcomes". Annals of Internal Medicine (İngilizce). 170 (7): 465-480. doi:10.7326/M18-3227. ISSN 0003-4819. PMID 30884526.